1. Home
  2. CCM vs LSTA Comparison

CCM vs LSTA Comparison

Compare CCM & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Concord Medical Services Holdings Limited

CCM

Concord Medical Services Holdings Limited

N/A

Current Price

$4.25

Market Cap

23.8M

Sector

Health Care

ML Signal

N/A

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

N/A

Current Price

$2.00

Market Cap

20.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCM
LSTA
Founded
1997
1980
Country
China
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Misc Health and Biotechnology Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.8M
20.9M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
CCM
LSTA
Price
$4.25
$2.00
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$23.50
AVG Volume (30 Days)
3.2K
23.9K
Earning Date
09-26-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$51,056,841.00
$1,070,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.54
$1.81
52 Week High
$10.77
$4.20

Technical Indicators

Market Signals
Indicator
CCM
LSTA
Relative Strength Index (RSI) 47.23 43.94
Support Level $4.12 $1.97
Resistance Level $4.99 $2.15
Average True Range (ATR) 0.26 0.12
MACD 0.10 0.02
Stochastic Oscillator 48.96 46.87

Price Performance

Historical Comparison
CCM
LSTA

About CCM Concord Medical Services Holdings Limited

Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: